MicroVision Inc

MVIS remains in a Stage 4 decline with a final capitulation flush but lacks constructive follow-through to confirm base-building. Medium-term bias stays bearish; execution is deferred into rallies toward declining EMA and SMA overhead. Short-term conditions are unfavorable for new entries, suggesting a trim into any strength around the moving average zone.

• ↑50% YoY revenue growth to $0.9M in Q1 2026
• ↑Gross margin rose from 7% to 39% YoY, guiding 35–40%
• ↓Negative earnings yield and poor profitability threaten sustainability